HBV infection activates STAT3 through the HBV X protein (HBx) and hepatitis B surface antigen (HBsAg), and the activated STAT3 interacts with different target genes, causing numerous effects on host antiviral immunity, viral replication and HCC [37,39]. This evidence concerns the gene STAT3 and hepatocellular carcinoma.